About the Testosterone Maintenance / Therapy Panel
Purpose of the test
This panel monitors the safety and effectiveness of TRT. It doesn’t diagnose low testosterone. If you’re wondering whether you need TRT in the first place, that’s a separate workup requiring two morning blood draws below 300 ng/dL plus symptoms of hypogonadism (low testosterone production).
Without regular monitoring, changes in red blood cell count, estradiol, liver function, or kidney function can go undetected. Skipping labs means erythrocytosis (excess red blood cell production) can develop quietly, raising blood thickness and cardiovascular risk. Estradiol imbalance can cause fluid retention or breast tissue changes before you notice anything.
The Endocrine Society’s 2018 clinical practice guideline recommends monitoring at three to six months after starting TRT, then annually once levels are stable.
This panel doesn’t screen for prostate cancer or replace a full endocrine evaluation.
What does the TRT test measure?
This panel covers four marker categories that may be affected by testosterone therapy. Your provider may order additional tests as necessary.
- Testosterone (free and total): Measures total testosterone in your blood and the unbound portion available to your tissues.
- Estradiol, ultrasensitive: Measures estradiol levels, since testosterone converts to estradiol via the aromatase enzyme.
- CBC with differential: Tracks red and white blood cell counts, hematocrit, and hemoglobin to catch polycythemia.
- Comprehensive metabolic panel (CMP): Checks liver, kidney, blood sugar, and electrolyte status.
One note on biotin: if you take biotin supplements (also sold as vitamin B7 or coenzyme R), common in hair, skin, and nail products, biotin can interfere with hormone assays and skew your results. Stop taking biotin at least 72 hours before your draw.
When should I get a TRT test?
Consider testing if any of these apply:
- Current enrollment in a testosterone replacement therapy program – 4-6 weeks after starting therapy and follow-up every 3-6 months
- Ongoing use of testosterone injections, pellets, gels, or patches
- Symptoms while on TRT: fatigue, mood changes, erectile dysfunction, fluid retention, or libido shifts
- A provider-recommended check-in to adjust your dose
- A gap in recent lab work while continuing therapy
- Desire to track liver health, blood thickness, and estrogen balance
- A transgender individual on testosterone therapy who needs monitoring
Monitoring TRT is important to avoid adverse effects from too little medication or too much. Hormonal imbalances can cause acne, fatigue, or breast tenderness, and should be further investigated. High estradiol levels can invoke volatile emotional episodes, while low estradiol can lead to joint pain and decreased libido.
For routine monitoring during TRT:
- Newly starting TRT: test at three months, then again at six months
- Stable TRT: test annually once levels are consistent
- After any dose adjustment: retest three months after each change
- Transgender individuals: discuss frequency with your prescribing provider, as targets differ from cisgender male protocols
How It Works
How to get tested
You can get this TRT blood test through a healthcare provider, clinic, or hospital lab. Testing.com connects you with CLIA-certified laboratory partners, including LabCorp and Quest Diagnostics, for in-lab blood draws. Results are delivered to your secure online account, and you’ll get an email when they’re ready.
Consumer-ordered TRT monitoring labs aren’t reported to employers, insurers, or military branches. Your results go only to you.
Before the test
TRT takes time to show positive effects. In general, wait 30 days before checking testosterone levels. Fast for at least eight hours before your draw. Water is fine. Skip food, juice, coffee, and other beverages. Stop taking biotin at least 72 hours before the draw. Biotin is common in hair, skin, and nail supplements and can interfere with hormone assays, producing inaccurate results. The FDA has flagged this interference in a safety communication. Tell your provider about all medications and supplements. Don’t stop any prescribed medication without guidance.
Schedule the draw between 7 and 10 a.m. Testosterone is highest in the morning. A late-afternoon draw can show lower levels that don’t reflect your actual hormone balance. Consult your provider to schedule the blood draw in order to obtain the most accurate picture of your therapy.
During the test
- A technician draws blood from a vein in your arm. It takes a few minutes. A small bandage covers the site afterward.
- Keep the bandage on for at least 15 minutes, then go about your day.
- Call your provider if you notice lasting pain, significant swelling, or signs of infection at the site.
This is a single blood draw. No waiting period, no multiple draws. You’ll feel a brief pinch. Some light bruising is normal. Feeling faint right after isn’t common, but is worth mentioning to the technician.
After the test
Results are typically ready within one to three business days after the lab receives your sample, though timing can vary by lab. You’ll get an email when they’re available in your secure online account.
If your test was ordered through a provider’s office, timing may vary depending on their portal.
What Do My Results Mean?
Your results come back as numbers across four marker categories. Your provider reads them together, not one by one, alongside your symptoms and therapy history. Reference ranges vary slightly between labs. Your results depend on the method of administration and the medication used, including dosing regimens, absorption rates, and half-lives of the medication. Timing of the blood draw relative to your injection schedule, your age, and your current symptoms can also influence test results. A single out-of-range result doesn’t automatically mean your dose needs to change. The National Library of Medicine’s testosterone test overview provides additional context on how reference ranges are applied.
| Marker | Typical Reference Range | Notes
|
| Total Testosterone (men) | 300–1,000 ng/dL | Therapeutic target on TRT is often 400–700 ng/dL |
| Free Testosterone (men) | 9–30 pg/mL | Calculated from total T, SHBG, and albumin |
| Estradiol, Ultrasensitive (men) | 10–40 pg/mL | Higher levels may point to aromatase activity |
| Hematocrit (CBC) | 38.5–50% (men) | Above ~54% may prompt a dose review per the Endocrine Society 2018 guideline |
| CMP markers | Varies by marker | Liver enzymes, kidney function, glucose, electrolytes |
If your results are in range
When all four marker categories are within the laboratory’s established reference ranges, therapy is working at your current dose. But “in range” doesn’t always mean symptoms are gone. If fatigue or other symptoms persist, your provider may look more closely at free testosterone, SHBG, or other factors (medication adherence, delivery method, other health issues like thyroid or liver problems. Routine monitoring continues on your established schedule, annually once you’re stable.
If your results are out of range
Here’s what specific findings often mean and what tends to happen next:
- High hematocrit (above ~54% in men): A common TRT side effect. Per the Endocrine Society’s hypogonadism guideline, your provider may lower your dose, change injection frequency, or recommend therapeutic phlebotomy (removing blood to bring red blood cell count down). Don’t stop therapy on your own.
- High estradiol: Aromatase may be converting excess testosterone to estradiol. Your provider may discuss an aromatase inhibitor or a dose change.
- Low free testosterone with normal total testosterone: High SHBG levels may be binding most of your testosterone, leaving little for your body to use. Your provider may check SHBG further or adjust your therapy.
- Abnormal CMP values: High liver enzymes, kidney function changes, or blood sugar shifts may prompt a review of other medications, lifestyle factors, your testosterone formulation, or broader men’s health screening.
Discuss your results with your prescribing provider and don’t adjust your dose based on lab numbers alone.
FAQs
Sources
- U.S. Food and Drug Administration. The FDA Warns That Biotin May Interfere With Lab Tests. 2019.
- Endocrine Society. Hypogonadism in Men. Updated January 24, 2022.
- Endocrine Society. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM, 2018.
- MedlinePlus. Testosterone Levels Test. National Library of Medicine.